As such, we demonstrate that both canonical and non-canonical STING signaling can participate in the rapid IL-6 production seen upon DNA damage in different cancer cells, indicating that the pro-tumorigenic activities of the pathway are not limited to its chronic engagement. Here, STING1 is linked to cancer.